allograft [OCA])
. 34 The large number of surgical options for chondral defects are evidence of the difficulty in replicating hyaline cartilage function (Table 1) .
Microfracture
Microfracture is a marrow stimulation technique considered the first-line treatment given its minimally invasive nature, technical ease, limited surgical morbidity, and relatively low cost ( Figures  1 and 2 ). 52 At a mean 7-year follow-up, 80% of patients rated themselves as improved after MF, with patients younger than 35 years showing the most improvement. 50 The mean size of chondral defect was 2.8 cm 2 . Of 25 National Football League players who underwent MF for treatment of full-thickness chondral lesions, three-fourths were able to return to football the following season for an average of almost 5 additional seasons. 51 Biopsies after MF have noted that approximately 10% had hyaline cartilage, with the majority having predominantly fibrocartilage. 25 Lesions less than 4 cm 2 were likely to respond better to MF in the first 2 years. Systematic reviews have similarly demonstrated clear improvement in knee function at 24 months after MF but inconclusive durability and treatment failure beyond 5 years. 16, 37 autologous Matrix-induced chondrogenesis Autologous matrix-induced chondrogenesis (AMIC) combines MF surgery with the application of a bilayer collagen membrane that physically stabilizes the clot and may guide and enhance marrow-derived repair. A multicenter, randomized controlled trial compared BST-CarGel (Piramal Life Sciences, BioOrthopaedic Division) treatment with MF alone in the repair of cartilage lesions in the knee. 49 At 12 months, BST-CarGel treatment resulted in greater lesion filling and superior repair tissue quality compared with MF treatment alone; however, clinical symptoms were equivalent between groups.
osteochondral autograft transfer
With the OAT technique, defects can be filled immediately with mature, hyaline articular cartilage. 20, 33 The area to be treated should not exceed 4 cm 2 , and donor site morbidity can be a concern.
20 Perpendicular access to the cartilage surface, either arthroscopically or via a mini-open technique, is critical to allow the donor plug to be flush to re-create the normal articular contour and contact pressures ( Figure 3) . 12, 26, 40 At up to 10 years postoperatively, good or excellent results were obtained in approximately 90% of patients undergoing femoral condyle or tibial plateau mosaicplasty. 20 Outcomes vary greatly depending on age, sex, and size of the lesion, with increased failure rates in patients older than 40 years, women, and defect size greater than 3 cm 2 . Results of 23 patients at 39-month follow-up showed good or excellent clinical results in 70% of cases (femoral condylar defects had greater rates of healing, nearly 90%) ( Figure 4 , a and b). 4 Almost 3 of 4 biopsies had hyaline-like appearance, but the repair tissue is not identical to hyaline cartilage, and fibrocartilage was found in some. 44 Durable clinical results have been shown up to 11 years after ACI treatment. 42 Firstgeneration ACI for large (mean, 5.33 cm 2 ), full-thickness, symptomatic chondral defects of the knee showed significant improvements in pain relief and functional outcome measures at 8-year follow-up. 3 In patients with at least 1 previously failed non-ACI treatment for an osteochondritis dissecans knee lesion, significant reduction in pain and improved function was noted for up to 4 years after ACI, despite the complexity and severity of these lesions. 8 However, treatment failure occurred in 1 of 5 patients in this series. ACI after failed microfracture is associated with a significantly greater failure rate and inferior clinical outcome when compared with ACI as a first-line treatment. 41 In a series of more than 200 patients treated with ACI for larger lesions (mean defect size, 8.4 ± 5.5 cm 2 ), ACI provided durable outcomes with a survivorship of 71% at 10 years and improved function in 75% of patients. 36 A history of prior marrow stimulation as well as the treatment of very large defects was associated with an increased risk of failure. Magnetic resonance imaging (MRI) is used to evaluate the cartilage preoperatively and at final follow-up using the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score. 32 In 23 patients (mean age, 30.5 ± 8.2 years) with full-thickness chondral lesions of the distal femur, ACI resulted in a substantial improvement in all clinical outcome parameters at 1 year and a mean 9.9 years postoperatively. 38 Younger patients with a shorter duration of preoperative symptoms and smaller defect sizes benefitted the most. MRI findings confirmed complete defect filling in one-half of patients at final follow-up.
coMparison of techniques
A comparison of the cartilage repair and restoration techniques is outlined in Table 2 .
Microfracture Versus Osteochondral Autograft Transfer
In a retrospective study, patients treated with MF or OAT mosaicplasty for symptomatic articular cartilage defects of the femoral condyles or trochlea had similar clinical outcomes at intermediate-term follow-up (up to 5 years). However, patients treated with OAT mosaicplasty maintained a superior level of athletic activity compared with those treated with MF. 28 The OAT group had better clinical scores, more normal-appearing cartilage on visual assessment, and a subjectively greater percentage of hyaline cartilage histologically, with more than 90% of athletes able to return to their preinjury level of sport compared with only 50% in the MF group. Clinical outcomes of MF were worse in lesions larger than 2 cm 2 , but there was no association between clinical outcomes and lesion size when treated with OAT. 18 No significant differences at long-term follow-up were seen between patients treated with MF or OAT mosaicplasty in patient-reported outcomes, muscle strength, or radiological outcome. 54 
Microfracture Versus Autologous Chondrocyte Implantation
At 2 years after surgery, there was little difference between the ACI and MF groups; the Short Form (SF)-36 physical component was the only score that revealed a difference that was significantly better for the MF group, possibly related to ACI being a 2-stage procedure. 25 Second-look arthroscopy performed in three-fourths of the participants 2 years after surgery showed no difference using the International Cartilage Repair Society (ICRS) grading system. 5 Similarly, biopsy specimens revealed no significant difference in hyaline cartilage or fibrocartilage in the repair tissues. Treatment failure at 5 years occurred in 1 of 4 patients in both groups. 
Second-and Third-Generation Autologous Chondrocyte Implantation
Forty-one professional or semiprofessional male soccer players were treated for full-thickness osteochondral defects over a 6-year period with either second-generation arthroscopic ACI (Hyalograft C) or MF. 27 More than 80% of participants in both groups returned to competition. MF allowed a faster recovery but presented a greater clinical deterioration over time, whereas ACI offered more durable clinical results.
A randomized clinical trial comparing first-generation ACI with a periosteal patch to third-generation matrix-associated ACI (MACI) showed improvement in clinical outcome measures at 12 months, but there was no difference between the 2 techniques. 55 
Osteochondral Autograft Transfer Versus Autologous Chondrocyte Implantation
In a prospective trial comparing ACI with OAT, no significant difference in patient-reported outcomes at 2 years was seen, with the exception of improved Lysholm scores in the OAT group during the first 24 months. 23 A larger trial of 100 patients randomized to either ACI or OAT demonstrated no significant difference between the groups at early follow-up. 1 At 10 years, 17% in the ACI group had a failed repair and 55% in the mosaicplasty group failed.
2 Surgical placement of a proud OAT graft explained the higher failure rate of the OAT cohort.
Microfracture Versus Osteochondral Autograft Transfer Versus Autologous Chondrocyte Implantation
In a prospective study with minimum 3-year follow-up, all 3 procedures (MF, OAT, and ACI) showed improvement in functional scores, with no differences between groups. 31 Arthroscopy at 1 year showed excellent or good results in 80% of patients, regardless of technique. MF appeared to be a reasonable option as a first-line therapy given its ease and significant affordability relative to ACI or OAT.
A recent systematic review found 13 studies (917 subjects) that met the study inclusion criteria. 21 Most of these were young patients undergoing cartilage repair or restoration with a long preoperative duration of knee symptoms with multiple previous surgical procedures (range, 0-13). The defects were moderately sized (range, 1.9-6.2 cm 2 ) and primarily located on the medial femoral condyle. All surgical techniques demonstrated improvement in comparison with the preoperative status. There was no clear benefit of ACI versus MF in short-term (<5 years) outcomes; however, clinical outcomes after MF deteriorated after 1.5 to 2 years. ACI and OAT demonstrated equivalent short-term clinical outcomes, although there was more rapid improvement after OAT. ACI yielded the greatest proportion of complications, with graft hypertrophy occurring in 22% of first-generation treatments, 5% of second-generation treatment, and 7% of third-generation (MACI) treatment. Arthrofibrosis occurred in 17% of OAT cases, 2.5% of ACI cases, and 0.4% of MF cases. Younger patients with a shorter preoperative duration of symptoms and fewer prior surgical procedures had the best outcomes after both ACI and MF. A defect size of >4 cm 2 was the only factor predictive of better outcomes when ACI was compared with other techniques.
osteochondral allograft transplantation
If a cartilage defect is too large for an autograft or a patient has failed a cartilage repair procedure, then a fresh OCA transplantation (mega-OAT) may be used ( Figure 5) . 46 OCA transplantation is a single-stage technique for large osteochondral defects, in the setting of extensive subchondral bone loss. 15 Chondrocyte viability directly correlates with the clinical success of OCA transplantation. 39 Fresh OCAs stored at physiologic temperature have the highest level of chondrocyte viability. 6 One hundred twenty-two patients (129 knees) underwent OCA of the femoral condyle with graft failure defined as revision or conversion to arthroplasty. 30 Survivorship was 82% at 10 years, 74% at 15 years, and 66% at 20 years. Forty-seven percent of patients underwent reoperations, and 24% failed at a mean 7.2 years. Patients older than 30 years at time of surgery and with 2 or more previous surgeries were associated with allograft failure.
A study on 60 patients with femoral condylar allografts showed 95% graft survival at 5 years and 85% at 10 years. 17 Unfortunately, limited data are available on the use of OCA transplantation in an athletic population. In a recent study with 2.5-year follow-up, nearly 80% had returned to sport at the preinjury level, with all collegiate and professional athletes able to return to play. 29 Risk factors for not returning to sport were older than 25 years and preoperative symptoms for longer than 12 months. steM cells, cartilage regeneration, and gene therapy
The treatment options discussed thus far result in the formation of predominantly fibrocartilage. The limited capacity of damaged cartilage to regenerate and the potential morbidity associated with implanting or transferring bone and cartilage make cartilage regeneration an attractive alternative. 53 The future of managing cartilage defects lies in providing biologic solutions through cartilage regeneration and tissue engineering.
Growth factors (eg, bone morphogenetic protein 2 [BMP-2] and fibroblast growth factor 2 [FGF-2]) are active molecules that can stimulate cell growth, enhance chondrogenesis, and augment the management of cartilage defects. Platelet-rich plasma (PRP) injections, which contain many of these growth factors, have shown promise as a possible solution to promote cartilage healing, improve clinical function, and decrease pain associated with cartilage lesions and osteoarthritis. 7, 9, 48 Other cartilage repair options are based on the concept that chondrocytes from morselized or particulated cartilage can migrate to form new hyaline-like repair tissue that integrates with surrounding tissue. Particulated juvenile articular cartilage (PJAC; DeNovo NT Natural Tissue Graft; Zimmer) consists of allograft articular cartilage from donors younger than 13 years.
14 A prospective study of 25 patients with 2-year follow-up (mean lesion size, 2.7 ± 0.8 cm 2 ) demonstrated clinical outcome scores that were significantly greater than baseline scores, and there were no failures. 13 Tissue samples taken at follow-up showed a mixture of hyaline and fibrocartilage with excellent integration of the transplanted tissue with the surrounding native articular cartilage.
Another treatment under investigation is gene therapy: using biologic factors to suppress cytokines (eg, tumor necrosis factors and interleukins). This has been useful in the management of rheumatoid arthritis. 35 In the case of osteoarthritis, only transforming growth factor (TGF)-β1 has been studied in the clinical setting; its potential application for focal osteochondral defects has not been determined. 19 
suMMary
In general, smaller lesions (<2 cm 2 ) are best treated with MF or OAT. OAT shows trends toward greater longevity and durability as well as improved outcomes in high-demand patients. Intermediate-size lesions (2-4 cm 2 ) have shown fairly equivalent treatment results using either OAT or ACI treatment options. For larger lesions (>4 cm 2 ), ACI or OCA have shown the best results, with OCA being an option for bone defects seen with large osteochondritis dissecans lesions. Each patient's treatment should be individualized taking into account lesion size, age, efficacy of treatment, patient preference, and cost (ie, ACI is a 2-stage procedure that is significantly more expensive and requires a longer rehabilitation period than OAT).
The "Holy Grail" for treatment of focal articular cartilage lesions has yet to be realized, as no single technique can reproduce normal hyaline cartilage. 45 The variety and depth of emerging technologies have the potential to revolutionize the field of cartilage repair and regeneration over the next decade.
SORT: Strength of Recommendation Taxonomy
A: consistent, good-quality patient-oriented evidence B: inconsistent or limited-quality patient-oriented evidence C: consensus, disease-oriented evidence, usual practice, expert opinion, or case series Clinical Recommendation
SORT Evidence Rating
Improved treatment outcomes for osteochondral lesions are seen in full-thickness lesions in patients younger than 40 years.
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A Each patient's treatment should be individualized taking into account lesion size, age, efficacy of treatment, patient preference, and cost. , OAT demonstrates greater durability and improved outcomes in high-demand athletic patients.
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